Literature DB >> 15273892

The relationship between energy expenditure and lean tissue in monozygotic twins discordant for spinal cord injury.

William A Bauman1, Ann M Spungen, Jack Wang, Richard N Pierson.   

Abstract

Energy expenditure and fat-free mass (FFM), as well as the relationships between these parameters, were investigated in thirteen pairs of monozygotic twins discordant for SCI. Basal energy expenditure (BEE) and resting energy expenditure (REE) were determined by indirect calorimetry. Measurements for FFM and fat mass were obtained by dual-energy x-ray absorptiometry. Total body potassium was determined by a 4-Pi whole-body counting chamber. Values are expressed as mean standard deviation. BEE and REE of the twins with SCI were significantly less than those of the able-bodied co-twins (1387 268 vs. 1660 324 kcal/d, p < 0.005, and 1682 388 vs. 1854 376 kcal/d, p < 0.05, respectively). Regardless of the group, direct and highly significant relationships were evident between BEE or REE and FFM or TBK. In summary, twins with SCI had lower energy expenditure than their able-bodied co-twins. Regardless of paralysis, direct linear relationships existed between energy expenditure and measures of lean mass.

Entities:  

Mesh:

Year:  2004        PMID: 15273892     DOI: 10.1682/jrrd.2004.01.0001

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  32 in total

Review 1.  An evidence-based review of aging of the body systems following spinal cord injury.

Authors:  S L Hitzig; J J Eng; W C Miller; B M Sakakibara
Journal:  Spinal Cord       Date:  2010-12-14       Impact factor: 2.772

Review 2.  Activity-Based Restorative Therapies after Spinal Cord Injury: Inter-institutional conceptions and perceptions.

Authors:  David R Dolbow; Ashraf S Gorgey; Albert C Recio; Steven A Stiens; Amanda C Curry; Cristina L Sadowsky; David R Gater; Rebecca Martin; John W McDonald
Journal:  Aging Dis       Date:  2015-08-01       Impact factor: 6.745

Review 3.  Effects of Use and Disuse on Non-paralyzed and Paralyzed Skeletal Muscles.

Authors:  David R Dolbow; Ashraf S Gorgey
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

4.  Identification and Management of Cardiometabolic Risk after Spinal Cord Injury.

Authors:  Mark S Nash; Suzanne L Groah; David R Gater; Trevor A Dyson-Hudson; Jesse A Lieberman; Jonathan Myers; Sunil Sabharwal; Allen J Taylor
Journal:  J Spinal Cord Med       Date:  2019-06-10       Impact factor: 1.985

5.  Resting energy expenditure in male athletes with a spinal cord injury.

Authors:  Fiona E Pelly; Elizabeth M Broad; Natalie Stuart; Mark A Holmes
Journal:  J Spinal Cord Med       Date:  2017-05-04       Impact factor: 1.985

6.  Identification and Management of Cardiometabolic Risk after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers.

Authors:  Mark S Nash; Suzanne L Groah; David R Gater; Trevor A Dyson-Hudson; Jesse A Lieberman; Jonathan Myers; Sunil Sabharwal; Allen J Taylor
Journal:  Top Spinal Cord Inj Rehabil       Date:  2018

7.  Estimation of resting energy expenditure in children with spinal cord injuries.

Authors:  Pamela L Patt; Sarah M Agena; Lawrence C Vogel; Sharon Foley; Caroline J Anderson
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

8.  Metabolic syndrome in adolescents with spinal cord dysfunction.

Authors:  Mindy Dopler Nelson; Lana M Widman; Richard Ted Abresch; Kimber Stanhope; Peter J Havel; Dennis M Styne; Craig M McDonald
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

Review 9.  Clinical assessment and management of obesity in individuals with spinal cord injury: a review.

Authors:  Suparna Rajan; Marguerite J McNeely; Catherine Warms; Barry Goldstein
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

10.  The role of nutrition in health status after spinal cord injury.

Authors:  Refka E Khalil; Ashraf S Gorgey; Milissa Janisko; David R Dolbow; Jewel R Moore; David R Gater
Journal:  Aging Dis       Date:  2012-11-30       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.